GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025 
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing 
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents 
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal 
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue 
Nvidia and Groq Strike Strategic AI Inference Licensing Deal 
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands 
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy 
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares 
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit 
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 
Dublin, Feb. 17, 2017 -- Research and Markets has announced the addition of the "Regenerative Medicine - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Regenerative Medicine in US$ Million.
The report profiles 52 companies including many key and niche players such as
- AlloSource (US)
- Anika Therapeutics, Inc. (US)
- Bioventus LLC (US)
- DePuy Synthes Companies (US)
- DePuy Synthes Spine, Inc. (US)
- Exactech, Inc. (US)
- Integra LifeSciences Holdings Corp. (US)
- LifeNet Health, Inc. (US)
- Medtronic, plc (Ireland)
- NovaBone Products LLC (US)
- NuVasive, Inc. (US)
- Orthofix International N.V. (Netherlands)
- Osiris Therapeutics, Inc. (US)
- Smith & Nephew plc (UK)
- Stryker Corporation (US)
- Wright Medical Technology, Inc. (US)
- Zimmer Biomet Holdings, Inc. (US)
Key Topics Covered:
1. Outlook
2. Regenerative Medicine A Macro Perspective
3. Bone And Joint Regenerative Medicine An Overview
4. Competitive Landscape
5. Regenerative Medicine In Other Areas
6. Regulatory Environment
7. A Peek Into The Global Orthopedic Industry
8. Product Overview
9. Product Innovations/Introductions
10. Recent Industry Activity
11. Focus On Select Players
12. Global Market Perspective
Total Companies Profiled: 52 (including Divisions/Subsidiaries 54)
- The United States (37)
- Canada (3)
- Japan (1)
- Europe (10)
- Germany (2)
- The United Kingdom (2)
- Rest of Europe (6)
- Asia-Pacific (Excluding Japan) (1)
- Middle East (1)
- Africa (1)
For more information about this report visit http://www.researchandmarkets.com/research/zzvd55/regenerative
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biopharmaceuticals
